Abstract
Glucose-conjugated malonato-platinum(II) complexes are designed and synthesized to target tumor-specific active transporters, namely, glucose transporters (GLUTs); the complexes exhibit much higher aqueous solubility by 150 times, improved potency in cytotoxicities by 10 times, and increased therapeutic index by over 30 fold compared to the newest generation of clinical drugs oxaliplatin.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry*
-
Antineoplastic Agents / toxicity
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Coordination Complexes / chemical synthesis
-
Coordination Complexes / chemistry*
-
Coordination Complexes / toxicity
-
Glucose / chemistry
-
Glucose Transport Proteins, Facilitative / antagonists & inhibitors
-
Glucose Transport Proteins, Facilitative / metabolism
-
HT29 Cells
-
Humans
-
MCF-7 Cells
-
Mice
-
Mice, Inbred BALB C
-
Mice, Nude
-
Platinum / chemistry*
-
Solubility
-
Water / chemistry
-
Weight Loss / drug effects
Substances
-
Antineoplastic Agents
-
Coordination Complexes
-
Glucose Transport Proteins, Facilitative
-
Water
-
Platinum
-
Glucose